Astrazeneca Covid 19 Vaccine

Looking back at how Pfizer-BioNTech won the COVID-19 vaccine race

BioNTech held webinars for nurses and doctors who will soon administer the shot, with 1,100 questions answered during the sessions.

India in talks with Moderna over COVID-19 vaccine development after biotech firm says its candidate shows 95% efficacy

'We are also in dialogue with Pfizer, Serum Institute, Bharat Biotech and Zydus Cadila for their vaccine candidate in terms of safety, immunogenicity and efficacy,' a government official said

Roll-out of Feluda test for detecting COVID-19 expected in next few weeks, says Harsh Vardhan

In the fifth episode of 'Sunday Samvaad', the health minister also said the decision on emergency use authorisation for vaccines against the virus will depend on results of the clinical trials

India records 83,809 new cases, COVID-19 tally crosses 49 lakh; 5 states account for 60% of active cases, says health ministry

India's COVID-19 caseload rose to 49,30,236 while the toll climbed to 80,776 with 1,054 people succumbing to the disease in 24 hours, the health ministry's data showed.

India readies five sites for final phase of human trials of Oxford's COVID-19 vaccine

Serum Institute of India has been chosen by Oxford University and its partner AstraZeneca to manufacture the COVID-19 vaccine

Coronavirus Outbreak: AstraZeneca in talks with governments to replicate UK vaccine deal

The UK aims to have 30 million doses of the vaccine ready by September if the human trial phase at Oxford University is successful.